Back to TCRX

MORGAN STANLEY → TCRX

MORGAN STANLEY TCRX Position History

TScan Therapeutics, Inc. • Healthcare

Quarters held
17
Latest value
$22K
Q3 2026
Peak value
$1.1M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$1.1M
Q3 2025$143K
Q3 2025$269K
Q3 2025$3K
Q4 2025$35K
Q4 2025$51K
Q4 2025$140K
Q1 2026$31K
Q1 2026$31K
Q1 2026$114K
Q2 2026$41K
Q2 2026$629
Q2 2026$1K
Q2 2026$151K
Q3 2026$10K
Q3 2026$877
Q3 2026$22K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$22K71.1K——
Q3 2026$8772.8K——
Q3 2026$10K30.8K——
Q2 2026$151K153.9K——
Q2 2026$1K1.4K——
Q2 2026$629642——
Q2 2026$41K41.9K——
Q1 2026$114K112.5K——
Q1 2026$31K30.3K——
Q1 2026$31K30.8K——
Q4 2025$140K140.4K——
Q4 2025$51K50.6K——
Q4 2025$35K34.8K——
Q3 2025$3K1.6K——
Q3 2025$269K148.0K——
Q3 2025$143K78.5K——
Q3 2025$1.1M619.4K——

Other funds holding TCRX

Other MORGAN STANLEY positions

AAPL

APPLE INC

$32.3B
AAPL

APPLE INC

$28.6B
AAPL

APPLE INC

$27.2B
AAPL

APPLE INC

$27.2B
NVDA

NVIDIA CORPORATION

$26.9B
AAPL

APPLE INC

$25.7B
AAPL

APPLE INC

$25.4B
AAPL

APPLE INC

$25.4B